Universal influenza vaccines: Shifting to better vaccines

Highlights • Current influenza vaccines are not broadly protective.• Developing countries suffer the highest morbidity and mortality due to influenza.• Correlates of protection and a regulatory pathway must be identified.• Over 40 universal influenza vaccine candidates are currently in development.

[1]  R. Compans,et al.  Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus. , 2013, Molecular Therapy.

[2]  David N. Taylor,et al.  Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. , 2011, Vaccine.

[3]  J. Shiver,et al.  Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. , 2009, Vaccine.

[4]  A. Fauci,et al.  Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine , 2010, Nature Medicine.

[5]  P. Palese,et al.  Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. , 2015, Current topics in microbiology and immunology.

[6]  D. Baltimore,et al.  Broad protection against influenza infection by vectored immunoprophylaxis in mice , 2013, Nature Biotechnology.

[7]  B. Futcher,et al.  Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice , 2013, Proceedings of the National Academy of Sciences.

[8]  A. Jegerlehner,et al.  Universal vaccine against influenza virus: Linking TLR signaling to anti‐viral protection , 2012, European journal of immunology.

[9]  D. Skowronski,et al.  Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. , 2013, Vaccine.

[10]  Mustafizur Rahman,et al.  Influenza is a Major Contributor to Childhood Pneumonia in a Tropical Developing Country , 2010, The Pediatric infectious disease journal.

[11]  R. Cortese,et al.  Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus , 2013, PloS one.

[12]  G. Wong,et al.  Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza , 2013, Science Translational Medicine.

[13]  D. G. Gibson,et al.  Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice , 2013, Emerging Microbes & Infections.

[14]  Harish Nair,et al.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis , 2011, The Lancet.

[15]  D. Pérez,et al.  Influenza Viruses with Rearranged Genomes as Live-Attenuated Vaccines , 2013, Journal of Virology.

[16]  S. Himanen,et al.  AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland , 2012, PloS one.

[17]  J. Chan,et al.  Cytotoxic T Cells Are the Predominant Players Providing Cross-Protective Immunity Induced by γ-Irradiated Influenza A Viruses , 2010, Journal of Virology.

[18]  Xuguang Li,et al.  Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes , 2014, Mucosal Immunology.

[19]  R. Rappuoli,et al.  An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine. , 2006, Vaccine.

[20]  J. Whittle,et al.  Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies , 2013, Nature.

[21]  Ying-hua Chen,et al.  N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication , 2003, FEMS Immunology and Medical Microbiology.

[22]  W. Fiers,et al.  Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. , 2008, Vaccine.

[23]  Brian Chin,et al.  Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis , 2006, The Lancet.

[24]  hristine B. Turleya,et al.  afety and immunogenicity of a recombinant M 2 e – flagellin influenza vaccine STF 2 . 4 xM 2 e ) in healthy adults , 2011 .

[25]  R. Compans,et al.  Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  J. Skehel,et al.  A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.

[27]  J. Katz,et al.  Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. , 2014, Vaccine.

[28]  J. Mascola,et al.  Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection , 2015, Nature Medicine.

[29]  M. Wolzt,et al.  Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1. , 2013, Vaccine.

[30]  T. Schlake,et al.  A novel, disruptive vaccination technology , 2013, Human vaccines & immunotherapeutics.

[31]  J. Langley,et al.  Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. , 2010, The Journal of infectious diseases.

[32]  N. S. Laursen,et al.  Highly Conserved Protective Epitopes on Influenza B Viruses , 2012, Science.

[33]  W. Fiers,et al.  An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2* , 2008, Journal of Biological Chemistry.

[34]  G. Rimmelzwaan,et al.  Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases , 2014, Viruses.

[35]  T. Ben-Yedidia,et al.  Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population. , 2014, Vaccine.

[36]  N. Sardesai,et al.  Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. , 2014, Vaccine.

[37]  Caitlin E. Mullarkey,et al.  Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1 , 2013, Scientific Reports.

[38]  T. Ross,et al.  Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades , 2015, Human vaccines & immunotherapeutics.

[39]  G. Stoloff,et al.  Synthetic multi‐epitope peptides identified in silico induce protective immunity against multiple influenza serotypes , 2007, European journal of immunology.

[40]  H. Jin,et al.  A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus HA Protein Affects Viral Fusion, Stability and Infectivity , 2014, PLoS pathogens.

[41]  Adrian Apetri,et al.  A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen , 2015, Science.

[42]  W. Fiers,et al.  CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. , 2008, Vaccine.

[43]  K. Broman,et al.  Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques , 2014, Journal of Virology.

[44]  R. Cox,et al.  An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans , 2014, Clinical and Vaccine Immunology.

[45]  Z. Xiang,et al.  A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  P. Palese,et al.  Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice , 2015, mBio.